Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Mol Pharm. 2012 Aug 15;9(9):2554–2564. doi: 10.1021/mp300165s

Table 1.

Ultrasound (US) enhanced recombinant MMP-9 triggered contents release from ELIPs.

Conditions Release (% ± SD) with
MMP-9
Release (% ± SD)
with US
Total Release (% ±
SD)
MMP-9 followed by US 62 ± 10 9 ± 1 71 ± 5
US followed by MMP-9 50 ± 12 15 ± 4 65 ± 10
Simultaneous 30 ± 2
Control (no US) 4 ± 4